A National Perspective on the Multidisciplinary Management of Breast Cancer Through the COVID-19 Pandemic

This OncLive® webinar will focus on the impact of COVID-19 in patients with breast cancer and the innovative ways in which treatment has evolved during this time. We will feature a panel of experts from the nation’s leading cancer centers, led by Eric P. Winer, MD, to discuss important topics and key information for treating patients with breast cancer.

Topics/Objectives:

• Regional differences in the management of patients with breast cancer during the COVID-19 pandemic
• Institutional best practices for treating patients with breast cancer that have the novel coronavirus or who may be at risk for developing it
• Guidelines on the prioritization and management of patients with breast cancer

Speakers:

Eric P. Winer, MD

Professor, Medicine, Harvard Medical School

Director, Breast Oncology Center, Dana-Farber Cancer Institute

Physician Active Staff, Medicine, Brigham And Women's Hospital

Thompson Chair, Breast Cancer Research, Dana-Farber Cancer Institute

Lisa A. Carey, MD , FASCO

Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research

Deputy Director of Clinical Sciences

Lineberger Comprehensive Cancer Center

George W. Sledge Jr, MD

Professor, Medicine and Oncology

Chief of the Division of Oncology, Stanford University Medical Center

Monica Morrow, MD, FACS

Chief, Breast Service, Department of Surgery

Anne Burnett Windfohr Chair of Clinical Oncology

Memorial Sloan Kettering Cancer Center

Professor of Surgery, Weill Cornell Medical College

Sponsored by : Novartis / In association with Dana Farber